Physician profile
John Scott Major
NPI 1487635777
$14,054.79
in general payments reported to CMS, 2019-2025
60 companies · $2,525 in 2025
The $2,525 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,149 · 2020: $1,574 · 2021: $2,436 · 2022: $1,893 · 2023: $2,458 · 2024: $2,019 · 2025: $2,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,001.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,132.90 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,875.42 | 2021-2025 | |
| Amgen INC. | $1,562.24 | 2019-2025 | Otezla, Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,535.03 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,158.47 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $948.48 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $426.08 | 2019-2023 | Xarelto, Spravato |
| Lilly USA, LLC | $264.65 | 2019-2025 | Jardiance, Emgality |
| Otsuka America Pharmaceutical, INC. | $256.37 | 2019-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $221.59 | 2019-2022 | |
| Allergan, INC. | $219.77 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $202.66 | 2019-2025 | Gardasil 9, Capvaxive |
| Corcept Therapeutics | $198.59 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $193.76 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $177.59 | 2019-2025 | Xifaxan, Trulance |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Major listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.